The aim of this study was to determine whether serum MMP7 identified NAFLD patients with clinically significant fibrosis based on elevated liver stiffness measurements, and to evaluate its diagnostic accuracy in combination with the ELF test. This evidence concerns the gene MMP7 and metabolic dysfunction-associated steatotic liver disease.